United States · Research startup
United States · Platelet BioGenesis, Inc.
PBG is a biotechnology company that researches and produces human platelets from induced pluripotent stem cells for the treatment of cancer.
Funding reportedLast round: Series B
What company datasets say Platelet BioGenesis, Inc. raised
Funding, as reported
Founders and team
From the SEC filings it signed: 1 on the team.
- Sam RastyExecutive Officer, Directori
On the board, as filediChidozie UgwumbaJoseph ItalianoMark McDadePhilip ReillyRichard MurraySteven Altschuler
On 2 portfolio pages
Investors who name them
Each firm lists Platelet BioGenesis, Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Built with from their website
Webflow HostingGoDaddy DomainsAmazon AWSRemoteProofpointGoDaddy HostingGoogle Search Console
- Sector
- Research
- Region
- Massachusetts
- Revenue
- $3.6M a year, as listed
- Full record
- Every detail in the company directory
Research in United States
Startups like it
Allen Institute for Cell ScienceSeattle · founded 2014
FermilabBatavia · founded 1968Broad InstituteCambridge · founded 2003
NCARBoulder · founded 1960- University Corporation for Atmospheric ResearchBoulder · founded 1960
Salk Institute for Biological StudiesLa Jolla · founded 1960
Monterey Bay Aquariam Research InstituteMoss Landing · founded 1987
Santa Fe InstituteSanta Fe · founded 1984
Is this your company?
Add your raise, your deck and your story, and put Platelet BioGenesis, Inc. in front of investors. Or tell us what we have wrong.